HHC and THC differ by one chemical step — and a widening legal gap. What the 2026 federal changes mean for each, state by state.
The Senate's funding bill pushes most of the hemp recriminalization to December 11 — but the House hasn't agreed, and synthetics still fall November 12.
Chemically a heat step apart, legally worlds apart — until the November 12 total-THC standard closes the gap. What operators and buyers need to know.
A new AG enforcement unit, a federal lawsuit, and a 2 mg cap all land in the same month. Virginia hemp retail is about to be the most-watched market in the country.
Texas went Schedule I on most hemp THC, Virginia stood up an enforcement unit before its 2 mg cap, and Delaware wrote the East Coast THC-drinks playbook.
The Texas Supreme Court cleared DSHS to enforce its 2021 schedule — and on July 31, most hemp THC products became Schedule I. Here are the ten facts that matter.
Three THC isomers, three legal stories. Which is strongest, which states ban which, and what November 12 changes for all of them.
Cannabis businesses pay surplus-lines prices for thin coverage because insurers fear federal exposure. A new bipartisan bill takes aim at exactly that.
Barr and Craig filed the first real vehicle to avert November 12 — with a 1% total THC standard and alcohol-style rules for THC drinks. THCA flower is left out.
CAOA was filed July 16 with a hemp-recriminalization block. Sen. Sheehy says a bipartisan fix can pass. Four months out, here are the realistic paths.
One is raw acid, one is a converted cannabinoid — and the law treats them very differently. A regulatory comparison with state-by-state links.
Massachusetts certified a ballot measure to roll back legalization — the first of its kind. A rundown of what it would change for the state's licensed market.
The evidentiary record is closed. The opposition's star witness conceded marijuana meets Schedule III criteria. Here's the timeline from ALJ recommendation to final rule.
NC lawmakers sent a compromise hemp THC, kratom, and xylazine bill to the governor. The total-THC standard redraws the state's THCA flower market.
Government witnesses defended cannabis's medical value while opponents attacked the FDA's test. Here's what happened in week one and what's left.
Though HHC and HHC-A share a chemical lineage, they are distinct compounds with different potency levels and legal statuses. Understanding the gap between "not yet illegal" and "confirmed legal" is essential for any consumer navigating today's complex cannabinoid market.
A 2026 guide to THCA legality in Texas, including how total-THC testing and the federal hemp redefinition affect THCA products.
The DEA's expedited rescheduling hearing runs June 29 to July 15. Who's testifying and what a Schedule III decision would change for operators.
Texas now counts THCA toward its THC limit, restricting THCA flower and concentrates. A look at the 2026 rule, the litigation, and the November federal cutover.
A regulatory guide to HHC vs THC: what HHC is, how it compares with delta-9 THC, and where its contested legal status stands in 2026.
The U.S. Embassy in Mexico warns World Cup travelers that importing marijuana, including medical cannabis, is illegal regardless of a U.S. state card.
A drug-testing trade group and a pharmaceutical company asked a federal appeals court to freeze marijuana rescheduling, reviving uncertainty over 280E relief and DEA registration.
THCA converts to delta-9 THC when heated. Here's how the law treats each and why the 2026 total-THC standard reshapes the THCA flower market.
How the law treats HHC vs THC, where they diverge, and what the 2026 federal changes mean for compliance.
Hemp companies have petitioned the Ninth and Fourth Circuits to overturn the DEA's Schedule I listing of HHC. Here's what HHC operators should do now.
State-by-state THCA status as of August 2026 with deep dives for Alabama, Georgia, North Carolina, South Carolina, and Texas — plus what changes when federal H.R. 5371 §781 takes effect November 12, 2026.
Texas hemp operators face TABC rule finalization, a March 31 smokable product ban, and HB 46 medical cannabis expansion reshaping the 2026 market.
Ontario's 2025 OCS THC potency testing pilot exposes label inflation in high-THC SKUs and reshapes supplier audits across the regulated adult-use catalog.
Oregon outdoor cannabis and hemp operators face 2025 wildfire smoke taint risks; practical guide to testing, labeling, and recall triage before packaging.
Greece's 2025 push to expand medical cannabis exports hinges on EU-GMP readiness across GACP cultivation, EudraLex Volume 4 manufacturing, and release.
Colombia's Decree 1138 of October 27, 2025 recognizes dried medical cannabis flower as a finished product, opening pharmacy dispensing and exports.
Health Canada removed the 60-day Notice of New Cannabis Product for dried and fresh cannabis in 2025, speeding flower launches without easing testing.
Colombia's 2025 VUCE foreign trade updates and Decree 1138 of 2025 reshape medical cannabis exports and authorize pharmacy flower under EU-GMP prescription.
Luxembourg ended prescription access to primarily THC-rich medical flower from January 1, 2025, favoring oils and standardized preparations for dosing.
Colombia's July 2025 draft decree and October 2025 Decree 1138 outline a prescription-only adult-use model dispensed through pharmacies under medical-gate.
Colombia's 2025 draft decree would authorize pharmacy sales of medical cannabis flower with new dispensing rules and marketing limits for licensed operators.
No — THCA is illegal outside Michigan's licensed cannabis system in 2026. CRA treats it as marijuana, not hemp. Retailer & consumer rules inside.
No — THCA smokables are a Class C felony in Alabama under HB 445 (July 2025). Edibles allowed under 10mg/serving, 40mg/package. ABC Board license required.
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
